Trulieve Opens Doors of Latest Dispensary, Reaching 25 Stores in State of Florida

The Miami Gardens dispensary makes Trulieve the first medical marijuana treatment center in the state to reach the milestone. Plus, Trulieve's response to the House and Senate vote.

MIAMI GARDENS, FL , March 14, 2019 /CNW/ - Trulieve Cannabis (OTC: TCNNF & CNSX: TRUL) ("Trulieve"), a leading and top performing cannabis company in the United States , is opening the doors of its 25^th storefront in Florida on Thursday: a new dispensary in Miami Gardens .

"As the patient registry continues to grow and new rules are adopted, we remain dedicated to providing reliable access to the patients that are looking for natural, direct relief," says Trulieve CEO Kim Rivers . "Expanding access across the state, especially throughout South Florida , is crucial as it's home to a large portion of patients. Our goal to ensure that all patients have access to high-quality, effective products in a space where they can feel comfortable and safe will always be our top priority."

Presently, Trulieve operates 24 other dispensaries throughout the state of Florida , including six more locations in Miami and throughout the South Florida region. As part of the company's mission to ensure safe, reliable access for patients statewide, Trulieve will continue opening stores as the patient registry and demand grows.

In stores and online, patients will find Florida's largest selection of THC and CBD products, available in a variety of delivery methods, including concentrates, ground flower for vaporizing, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients unable to make it to a physical store, in addition to its 25 dispensaries in locations across the state.

The Office of Medical Marijuana Use recently announced the registry had surpassed 190,000 registered medical marijuana patients with an active ID card, with Trulieve consistently selling between 60%-70% of the state's overall volume, per the Florida Department of Health. There are currently more than 2,000 registered ordering physicians in the state of Florida as well.

To celebrate their newest store, Trulieve will be holding a press conference with CEO Kim Rivers on Thursday, March 14th at 10:00 AM , with doors opening and press tours of the new dispensary immediately following.

WHAT: Trulieve Miami Gardens Grand Opening
WHERE: 18350 NW 47th Avenue, Miami Gardens, Florida 33055
WHEN: Thursday, March 14, 2019 at 10:00 AM

Trulieve Statement About House Vote to Repeal Smoking Ban

"We commend the House and Senate for working quickly on the repeal of the ban on smokable flower. We have received several inquiries on how quickly Trulieve plans to sell whole-flower cannabis.

"Please be advised that, as of this writing, whole-flower cannabis is still not legal until Governor DeSantis signs the bill into law and the Office of Medical Marijuana Use establishes rules and guidelines.

"As such, we at Trulieve understand patients' urgency in getting immediate access to this form of medicine and are working to be as ready as possible for when approval is granted. We have been and will continue to provide the largest variety of safe, reliable, and high-quality medicinal cannabis in Florida ."

About Trulieve 
Trulieve Cannabis Corp. is a vertically integrated "seed to sale" company and is the first and largest fully licensed cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery. Trulieve also operates in California and Massachusetts .

Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL.

This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.